Magnetic resonance imaging with spectroscopy, perfusion and cerebral diffusion in the diagnosis of brain tumours;Resonancia magnética con espectroscopia, perfusión y difusión cerebral en el diagnóstico de los tumores cerebrales

Revista de Neurologia

Volumn 42, Issue 12, 2006, Pages 735-742

  Fayed Miguel, N ^a   Morales Ramos, H ^a   Modrego Pardo, P J ^b  

^a HOSPITAL QUIRÓN   (Spain)

^b HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

Author keywords

Brain tumor; Diffusion; Magnetic resonance imaging; Perfusion; Spectroscopy

Indexed keywords

CHOLINE; CREATININE; GADOLINIUM PENTETATE MEGLUMINE; N ACETYLASPARTIC ACID; ASPARTIC ACID; CONTRAST MEDIUM; DRUG DERIVATIVE; N-ACETYLASPARTATE; TUMOR MARKER;

ANGIOGENESIS; ANISOTROPY; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN PERFUSION; BRAIN TUMOR; DIFFUSION WEIGHTED IMAGING; HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REVIEW; TUMOR BIOPSY; ARTICLE; BRAIN CIRCULATION; BRAIN LEVEL; CANCER STAGING; CHEMISTRY; IMAGE PROCESSING; METABOLISM; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PERMEABILITY; PHYSIOLOGY; PROGNOSIS;

ASPARTIC ACID; BLOOD-BRAIN BARRIER; BRAIN CHEMISTRY; BRAIN NEOPLASMS; CEREBROVASCULAR CIRCULATION; CHOLINE; CONTRAST MEDIA; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; NEOPLASM STAGING; PERMEABILITY; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 33750135713     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4212.2005120     Document Type: Review

References (77)

1. Maheshwari S, Fatterpeaker G, Castillo M, Murkherji SK. Proton MR spectroscopy of the brain. Semin Ultrasound CT MR 2000; 21:434-51.
2. Bonavita S, Di Salle F, Tedeschi G. Proton MRS in neurological disease. Eur J Radiol 1999; 30: 125-31.
3. Castillo M, Kwock L, Mukherji SK. Clinical applications of proton MR spectroscopy. AJNR Am J Neuroradiol 1996; 17: 1-15.
4. Sauter R, Schneider M, Wicklow K, Kolem H. Localized 1H MRS of the human brain: single-voxel versus CSI techniques. J Magn Reson Imaging 1991; 1: 241.
5. Hsu YY, Chang C, Chang CN, Chu NS, Lim KE, Hsu JC. Proton MR spectroscopy in patients with complex partial seizures: single-voxel spectroscopy versus chemical-shift imaging. AJNR Am J Neuroradiol 1999; 20: 643-51.
6. Hsu YY, Chen MC, Lim KE, Chang C. Reproducibility of hippocampal single-voxel proton MR spectroscopy and chemical shift imaging. AJR Am J Roentgenol 2001; 176: 529-36.
7. Law M. MR spectroscopy of brain tumors. Top Magn Reson Imaging 2004; 15: 291-313.
8. Majós C, Juliá-Sapé M, Alonso J, Serrallonga M, et al. Brain tumor classification by proton MR spectroscopy: comparison of diagnostic accuracy at short and long TE. AJNR Am J Neuroradiol 2004; 25: 1696-704.
9. Law M, Meltzer DE, Cha S. Spectroscopic magnetic resonance imaging of a tumefactive demyelinating lesion. Neuroradiology 2002; 44: 986-9.
10. Saindane AM, Cha S, Law M, Xue X, Knopp EA, Zagzag D. Proton MR Spectroscopy of tumefactive demyelinating lesions. AJNR Am J Neuroradiol 2002; 23: 1378-86.
11. Shimizu H, Kumabe T, Tominaga T, Kayama T, Hara K, Ono Y, et al. Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy. AJNR Am J Neuroradiol 1996; 17: 737-47.
12. Harting I, Hartmann M, Jost G, Sommer C, Ahmadi R, Heiland S, et al. Differentiating primary central nervous system lymphoma from glioma in humans using localized proton magnetic resonance spectroscopy. Neurosci Lett 2003; 342: 163-6.
13. Fayed N, Modrego P. The contribution of magnetic resonance spectroscopy and echoplanar perfusion-weighted MRI in the initial assessment of brain tumors. J Neurooncol 2005; 72: 261-5.
14. Sabatier J, Gilard V, Malet-Martino M, Ranjeva JP, Terral C, Breil S, et al. Characterization of choline compounds with in vitro 1H magnetic resonance spectroscopy for the discrimination of primary brain tumors. Invest Radiol 1999; 34: 230-5.
15. Fan G, Sun B, Wu Z, Guo Q, Guo Y. In vivo single-voxel proton MR spectroscopy in the differentiation of high-grade gliomas and solitary metastases. Clin Radiol 2004; 59: 77-85.
16. Nelson SJ, McKnight TR, Henry RG. Characterization of untreated gliomas by magnetic resonance spectroscopy imaging. Neuroimaging Clin North Am 2002; 12: 599-613.
17. Moller-Hartmann W, Herminghaus S, Krings T, Marquardt G, Lanfermann H, Pilatus U, et al. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 2002; 44: 371-81.
18. Law M, Cha S, Knopp EA, Johnson G, Arnett J, Litt AW. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopy MR imaging. Radiology 2002; 222: 715-21.
19. Howe FA, Barton SJ, Cudlip SA, Stubbs M, Saunders DE, Murphy M, et al. Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med 2003; 49: 223-32.
20. Majos C, Alonso J, Aguilera C, Serrallonga M, Pérez-Martín J, Acebes JJ, et al. Proton magnetic resonance spectroscopy of human brain tumors: assessment of differences between tumor type and its applicability in brain tumor categorization. Eur Radiol 2003; 13: 582-91.
21. Castillo M, Smith JK, Kwock L. Correlation of myo-inositol levels and grading of cerebral astrocytomas. AJNR Am J Neuroradiol 2000; 21: 1645-9.
22. Croteau D, Scarpace L, Hearshen D, Gutiérrez J, Fisher JL, Rock JP, et al. Correlation between magnetic resonance spectroscopy imaging and image-guided biopsies: semiquantitative and qualitative histopathological analysis of patients with untreated glioma. Neurosurgery 2001; 49: 823-9.
23. Bulakbasi N, Kocaoglu M, Ors F, Tayfun C, Ucoz T. Combination of single-voxel proton MR spectrocopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors. AJNR Am J Neuroradiol 2003; 24: 225-33.
24. Petrella J, Provenzale JM. MR perfusion imaging of the brain: techniques and applications. AJR Am J Roentgenol 2000; 175: 207-19.
25. Aksoy FG, Lev MH. Dynamic contrast-enhanced brain perfusion imaging: technique and applications. Semin Ultrasound CT MR 2000; 21: 462-77.
26. Covarrubias DJ, Rosen BR, Lev MH. Dynamic magnetic resonance perfusion imaging of brain tumors. Oncologist 2004; 9: 528-37.
27. Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D. Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 2002; 223: 11-29.
28. Cha S. Perfusion MR imaging in brain tumors. Top Magn Reson Imaging 2004; 15: 279-89.
29. Sugahara T, Korogi Y, Kochi M, Ikushima I, Hirai T, Okuda T, et al. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol 1998; 171: 1479-86.
30. Henry RG, Vigneron DB, Fischbein NJ, Grant PE, Day MR, Noworolski SM, et al. Comparison of relative cerebral blood volume and proton spectroscopy in patients with treated gliomas. AJNR Am J Neuroradiol 2000; 21: 357-66.
31. 2-weighted MR imaging. Radiology 1999; 211: 791-8.
32. Law M, Yang S, Wang H, Babb JS, Johnson G, Cha S, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopy imaging compared with conventional MR imaging. AJNR Am J Neuroradiol. 2003; 24: 1989-98.
33. Murphy M, Loosemore A, Clifton AG, Howe FA, Tate AR, Cudlip SA, et al. The contribution of magnetic resonance spectroscopy (1HRMS) to clinical brain tumor diagnosis. Br J Neurosurg 2002; 16: 329-34.
34. Law M, Yang S, Babb JS, Knopp EA, Golfinos JG, Zagzag D, et al. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhancement perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 2004; 25: 746-55.
35. Shin JH, Lee HK, Kwun BD, Kim JS, Kang W, Choi CG, et al. Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results. AJR Am J Roentgenol 2002; 179: 783-9.
36. Lev MH, Ozsunar Y, Henson JW, Rasheed AA, Barest GD, Harsh GR 4th, et al. Glial tumor gradinng and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated cVBV of oligodendrogliomas. AJNR Am J Neuroradiol 2004; 25: 214-21.
37. Roberts HC, Roberts TP, Bollen AW, Ley S, Brasch RC, Dillon WP. Correlation of microvascular permeability derived from dynamic contrast-enhanced MR imaging with histologic grade and tumor labelling index: a study in human brain tumors. Acad Radiol 2001; 8: 384-91.
38. Sugahara T, Korogi Y, Tomiguchi S, Shigematsu Y, Ikushima I, Kira T, et al. Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. AJNR Am J Neuroradiol 2000; 21: 901-9.
39. Castillo M, Mukherji SK. Diffusion-weighted imaging in the evaluation of intracranial lesions. Semin Ultrasound CT MR 2000; 21: 405-16.
40. Moritani T, Shrier DA, Numaguchi Y, Takase Y, Takahashi C, Wang HZ, et al. Diffusion-weighted echo-planar MR imaging: clinical applications and pitfalls, a pictorial essay. Clin Imaging 2000; 24: 181-92.
41. Schaefer P, Grant E, Gonzales G. Diffusion-weighted MR imaging of the brain. Radiology 2000; 217: 331-45.
42. Ebisu T, Tanaka C, Umeda M, Kitamura M, Naruse S, Higuchi T, et al. Discrimination of brain abscess from necrotic or cystic tumors by diffusion-weighted echo planar imaging. Magn Reson Imaging 1996; 14: 1113-6.
43. Okamoto K, Ito J, Ishikawa K, Sakai K, Tokiguchi S. Diffusion-weighted echo-planar MR imaging in differential diagnosis of brain tumors and tumor-like conditions. Eur Radiol 2000; 10: 1342-50.
44. Dutt SN, Mirza S, Chavda SV, Irving RM. Radiologic differentiation of intracranial epidermoids from arachnoid cysts. Otol Neurotol 2002; 23: 84-92.
45. Camacho DL, Smith JK, Castillo M. Differentiation of toxoplasmosis and lymphoma in AIDS patients by using apparent diffusion coefficients. AJNR Am J Neuroradiol 2003; 24: 633-7.
46. Bulakbasi N, Guvenc I, Onguru O, Erdogan E, Tayfun C, Ucoz T. The added value of the apparent diffusion coefficient calculation to magnetic resonance imaging in the differentiation and grading of malignant brain tumors. J Comput Assist Tomogr 2004; 28: 735-46.
47. Brunberg JA, Chenevert TL, McKeever PE, Ross DA, Junck LR, Muraszko KM, et al. In vivo MR determination of water diffusion coefficients and diffusion anisotropy: correlation with structural alteration in gliomas of the cerebral hemispheres. AJNR Am J Neuroradiol 1995; 16: 361-71.
48. Sugahara T, Korogi Y, Kochi M, Ikushima I, Shigematu Y, Hirai T, et al. Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 1999; 9: 53-60.
49. Stadnik TW, Chaskis C, Michotte A, Shabana WM, Van Rompaey K, Luypaert R, et al. Diffusion-weighted MR imaging of intracerebral masses: comparison with conventional MR imaging and histologic findings. AJNR Am J Neuroradiol 2001; 22: 969-76.
50. Kono K, Inoue Y, Nakayama K, Shakudo M, Morino M, Ohata K, et al. The role of diffusion-weighted imaging in patients with brain tumors. AJNR Am J Neuroradiol 2001; 22: 1081-8.
51. Filippi CG, Edgar MA, Ulug AM, Prowda JC, Heier LA, Zimmerman RD. Appearance of meningiomas on diffusion-weighted images: correlating diffusion constants with histopathologic findings. AJNR Am J Neuroradiol 2001; 22: 65-72.
52. Guo AC, Cummings TJ, Dash RC, Provenzale JM. Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology 2002; 224: 177-83.
53. Sinha S, Bastin ME, Whittle IR, Wardlaw JM. Diffusion tensor MR imaging of high-grade cerebral gliomas. AJNR Am J Neuroradiol 2002; 23: 520-7.
54. 1 values in peritumoral oedematous brain. Neuroreport 2002; 13: 1335-40.
55. Sadeghi N, Camby I, Goldman S, Gabius HJ, Baleriaux D, Salmon I, et al. Effect of hydrophilic components of the extracellular matrix on quantifiable diffusion-weighted imaging of human gliomas: preliminary results of correlating apparent diffusion coefficient values and hyaluronan expression level. AJR Am J Roentgenol 2003; 18: 235-41.
56. Tien RD, Felsberg GJ, Friedman H, Brown M, MacFall J. MR imaging of high-grade cerebral gliomas: value of diffusion-weighted echoplanar pulse sequences. AJR Am J Roentgenol 1994; 162: 671-7.
57. Krabbe K, Gideon P, Wagn P, Hansen U, Thomsen C, Madsen F. MR diffusion imaging of human intracranial tumours. Neuroradiology 1997; 39: 483-9.
58. Castillo M, Smith JK, Kwock L, Wilber K. Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas. AJNR Am J Neuroradiol 2001; 22: 60-4.
59. Lu S, Ahn D, Johnson G, Cha S. Peritumoral diffusion tensor imaging of high-grade gliomas and metastatic brain tumors. AJNR Am J Neuroradiol 2003; 24: 937-41.
60. Lu S, Ahn D, Johnson G, Law M, Zagzag D, Grossman RI. Diffusion-tensor MR imaging of intracranial neoplasia and associated peritumoral edema: introduction of the tumor infiltration index. Radiology 2004; 232: 221-8.
61. Provenzale JM, McGraw P, Mhatre P, Guo AC, Delong D. Peritumoral brain regions in gliomas and meningiomas: investigation with isotropic diffusion-weighted MR imaging and diffusion-tensor MR imaging. Radiology 2004; 232: 451-60.
62. Hein PA, Eskey CJ, Dunn JF, Hug EB. Diffusion-weighted imaging in the follow-up of treated high-grade gliomas: tumor recurrence versus radiation injury. AJNR Am J Neuroradiol 2004; 25: 201-9.
63. Chenevert TL, Meyer CR, Moffat BA, Rehemtulla A, Mukherji SK, Gebarski SS, et al. Diffusion MRI: a new strategy for assessment of cancer therapeutic efficacy. Mol Imaging 2002; 1: 336-43.
64. Ross BD, Moffat BA, Lawrence TS, Mukherji SK, Gebarski SS, Quint DJ, et al. Evaluation of cancer therapy using diffusion magnetic resonance imaging. Mol Cancer Ther 2003; 2: 581-7.
65. Mori S, Frederiksen K, Van Zijl PC, Stieltjes B, Kraut MA, Solaiyappan M, et al. Brain white matter anatomy of tumor patients evaluated with diffusion tensor imaging. Ann Neurol 2002; 51: 377-80.
66. Clark CA, Barrick TR, Murphy MM, Bell BA. White matter fiber tracking in patients with space-occupying lesions of the brain: a new technique for neurosurgical planning? Neuroimage 2003; 20: 1601-8.
67. Laundre BJ, Jellison BJ, Badie B, Alexander AL, Field AS. Diffusion tensor imaging of the corticospinal tract before and after mass resection as correlated with clinical motor findings: preliminary data. AJNR Am J Neuroradiol 2005; 26: 791-6.
68. Wieshmann UC, Symms MR, Parker GJ, Clark CA, Lemieux L, Barker GJ, et al. Diffusion tensor imaging demonstrates deviation of fibres in normal appearing white matter adjacent to a brain tumour. J Neurol Neurosurg Psychiatry 2000; 68: 501-3.
69. Holodny AI, Schwartz TH, Ollenschleger M, Liu WC, Schulder M. Tumor involvement of the corticospinal tract: diffusion magnetic resonance tractography with intraoperative correlation. J Neurosurg 2001; 95: 1082.
70. Holodny AI, Ollenschleger MD, Liu WC, Schulder M, Kalnin AJ. Identification of the corticospinal tracts achieved using blood-oxygen-level- dependent and diffusion functional MR imaging in patients with brain tumors. AJNR Am J Neuroradiol 2001; 22: 83-8.
71. Witwer BP, Moftakhar R, Hasan KM, Deshmukh P, Haughton V, Fiel A, et al. Diffusion tensor imaging of white matter tracts in patients with cerebral neoplasm. J Neurosurg 2002; 97: 568-75.
72. Moller-Hartmann W, Krings T, Coenen VA, Mayfrank L, Weidemann J, Kranzlein H, et al. Preoperative assessment of motor cortex and pyramidal tracts in central cavernoma employing functional and diffusion-weighted magnetic resonance imaging. Surg Neurol 2002; 58: 302-7.
73. Coenen VA, Krings T, Axer H, Weidemann J, Kranzlein H, Hans FJ, et al. Intraoperative three-dimensional visualization of the pyramidal tract in a neuronavigation system (PTV) reliably predicts true position of principal motor pathways. Surg Neurol 2003; 60: 381-90.
74. Hendler T, Pianka P, Sigal M, Kafri M, Ben-Bashat D, Constantini S, et al. Delineating gray and white matter involvement in brain lesions: three-dimensional alignment of functional magnetic resonance and diffusion-tensor imaging. J Neurosurg 2003; 99: 1018-27.
75. Parmar H, Sitoh YY, Yeo TT. Combined magnetic resonance tractography and functional magnetic resonance imaging in evaluation of brain tumors involving the motor system. J Comput Assist Tomogr 2004; 28: 551-6.
76. Khong PL, Kwong DL, Chan GC, Sham JS, Chan FL, Ooi GC. Diffusion-tensor imaging for the detection and quantification of treatment-induced white matter injury in children with medulloblastoma: a pilot study. AJNR Am J Neuroradiol 2003; 24: 734-40.
77. Leung LH, Ooi GC, Kwong DL, Chan GC, Cao G, Khong PL. White-matter diffusion anisotropy after chemo-irradiation: a statistical parametric mapping study and histogram analysis. Neuroimage 2004; 21: 261-8.